JAPAC Drug Development: Navigating Safety & Regulatory Requirements
HIT Consultant
APRIL 15, 2024
Jayawant Fuke, Senior Director of Lifecycle Safety, IQVI Hye Jin Choi, R. Director of Regulatory Affairs and Drug Development Solutions, IQVIA Asia Pacific The biopharmaceutical market within the Japan and Asia-Pacific (JAPAC) region has grown consistently since 2010, specifically for emerging biopharmas (EBPs).
Let's personalize your content